FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Propylthiouracil submitted by Actavis Pharma, Inc., reflecting an update to the product's labeling/approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperthyroidism

Drugs mentioned

• Propylthiouracil (propylthiouracil)

Snippet

SUPPL AP for PROPYLTHIOURACIL (PROPYLTHIOURACIL)